The Epidemic Within the Pandemic: Managing Complications in Populations with Obesity

Obesity is increasingly recognized as a multi-causal chronic disease that leads to structural and physiological abnormalities and functional impairments. Despite the growing prevalence and substantial burden of obesity in terms of health-related quality of life (HRQoL), healthcare utilization, and healthcare costs, obesity remains under-diagnosed and under-treated. The recent recognition that obesity is associated with increased risk of morbidity and mortality with coronavirus disease 2019 (COVID-19) shines a light on the fact that obesity is characterized by higher prevalence of physiologic alterations, such as chronic inflammation and impaired respiratory function, when compared to the non-obese state.

This live and OnDemand webcast will include interactive animated 3-D models, and a live Q&A session. The discussion, led by expert faculty, will cover pathophysiological features of obesity that influence weight loss, guidelines for screening, diagnosis, and patient counseling, and how to assess efficacy and safety of available and emerging therapies for long-term treatment of obesity.

Learning Objectives
At the end of this CME/CE activity, participants should be able to:
- Identify pathophysiological features of obesity that influence weight loss and maintenance.
- Apply guidelines for screening, diagnosis, and patient counseling for obesity and obesity-related disorders.
- Assess efficacy and safety of available and emerging therapies for long-term treatment of obesity.

The following learning objectives pertain only to those requesting CNE or CPE credit:
- Identify pathophysiological features of obesity that influence weight loss and maintenance.
- Summarize guidelines for screening, diagnosis, and patient counseling for obesity and obesity-related disorders.
- Describe the efficacy and safety of available and emerging therapies for long-term treatment of obesity.